<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00403078</url>
  </required_header>
  <id_info>
    <org_study_id>P06-3603</org_study_id>
    <nct_id>NCT00403078</nct_id>
  </id_info>
  <brief_title>SAPPHIRE Worldwide: Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy</brief_title>
  <official_title>Stenting and Angioplasty With Protection in Patients At High-Risk for Endarterectomy (SAPPHIRE Worldwide)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cordis Corporation</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cordis Corporation</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary objective of this study is to assess the outcomes of stenting with distal
      protection in the treatment of obstructive carotid artery disease. The devices to be utilized
      are the Cordis PRECISE® Nitinol Stent Systems (5.5F and 6F) and the Cordis ANGIOGUARD™ XP
      Emboli Capture Guidewire (ECGW).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Carotid Artery Stenting
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>October 2006</start_date>
  <completion_date type="Anticipated">November 2014</completion_date>
  <primary_completion_date type="Anticipated">July 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Any death, stroke or any MI</measure>
    <time_frame>up to 30-days post-procedure</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Assess the consistency of MAE rates of stenting with distal protection in the treatment of obstructive carotid artery disease among high, medium and low volume centers with physicians who have validated CASES training levels of 1, 2, 2P or 3</measure>
    <time_frame>30 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Assess the real-world cost-effectiveness of carotid artery stenting in subjects enrolled</measure>
    <time_frame>Every follow-up where a PRO instrument QoL was assessed</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimate MAE (death and ipsilateral stroke) rate in a subset of the planned total enrollment</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <enrollment type="Anticipated">21000</enrollment>
  <condition>Carotid Artery Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Study population will consist of high-surgical risk patients with atherosclerotic disease
        of the carotid artery(ies) from up to 350 clinical sites in the US and Canada.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  High-surgical risk patients to be treated consistent with IFU labeling

          -  The patient or legally authorized representative has signed a written informed consent
             and HIPAA authorization, prior to the procedure, using a form that is approved by the
             Institutional Review Board or Medical Ethics Committee.

        Exclusion Criteria:

          -  Patients not treated per the IFU

          -  Patients who are contraindicated per the IFU

          -  Patients previously enrolled in the study

          -  Patients requiring stenting of in-stent restenosis after CAS

          -  Inability or refusal to provide informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Rajesh Dave, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Harrisburg Hospital, 2808 Old Post Rd., Harrisburg, PA 17110</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Robert Hibbard, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Bryan LGH Heart Institute, 1500 South 48th St, Suite 400, Lincoln, NE 68506</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Douglas Massop, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Iowa Clinic-Heart and Vascular Care, 5950 University Ave, West Des Moines, IA 50266</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Christopher Metzger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Heart Center, PC, 2050 Meadowview Parkway, Kingsport, TN 37660</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Clinical Trial Triage</last_name>
    <phone>877-820-TRIAL</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Amy Orlick</last_name>
    <phone>908-541-4347</phone>
    <email>aorlick@its.jnj.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Christiana Care Health Services</name>
      <address>
        <city>Newark</city>
        <state>Delaware</state>
        <zip>19713</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ashish Parikh, M.D.</last_name>
      <phone>302-733-2658</phone>
    </contact>
    <investigator>
      <last_name>Ashish Parikh, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Iowa Clinic, Heart &amp; Vascular Care</name>
      <address>
        <city>West Des Moines</city>
        <state>Iowa</state>
        <zip>50266</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Douglas Massop, MD</last_name>
      <phone>515-875-9090</phone>
    </contact>
    <investigator>
      <last_name>Douglas Massop, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Bryan LGH Heart Institute</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Robert Hibbard, MD</last_name>
      <phone>402-483-3333</phone>
    </contact>
    <investigator>
      <last_name>Robert Hibbard, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Harrisburg Hospital</name>
      <address>
        <city>Harrisburg</city>
        <state>Pennsylvania</state>
        <zip>17110</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Rajesh Dave, MD</last_name>
      <phone>717-920-4400</phone>
    </contact>
    <investigator>
      <last_name>Rajesh Dave, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>The Heart Center, PC</name>
      <address>
        <city>Kingsport</city>
        <state>Tennessee</state>
        <zip>37660</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Christopher Metzger, MD</last_name>
      <phone>423-230-5640</phone>
    </contact>
    <investigator>
      <last_name>Christopher Metzger, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Massop D, Dave R, Metzger C, Bachinsky W, Solis M, Shah R, Schultz G, Schreiber T, Ashchi M, Hibbard R; SAPPHIRE Worldwide Investigators. Stenting and angioplasty with protection in patients at high-risk for endarterectomy: SAPPHIRE Worldwide Registry first 2,001 patients. Catheter Cardiovasc Interv. 2009 Feb 1;73(2):129-36. doi: 10.1002/ccd.21844.</citation>
    <PMID>18924164</PMID>
  </results_reference>
  <verification_date>February 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 20, 2006</study_first_submitted>
  <study_first_submitted_qc>November 22, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 23, 2006</study_first_posted>
  <last_update_submitted>February 7, 2014</last_update_submitted>
  <last_update_submitted_qc>February 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 10, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Carotid Artery Stenting (Endovascular)</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Artery Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

